title: Focus.
authors.affiliation: Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, United States. scott.friedman@mssm.edu
authors.forename: Scott L
authors.initials: SL
authors.lastname: Friedman
mesh_terms: D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D058750:Epithelial-Mesenchymal Transition / Q000502:physiology*; D006504:Hepatic Veno-Occlusive Disease / Q000139:chemically induced* / Q000517:prevention & control*; D006526:Hepatitis C / Q000150:complications*; D022781:Hepatocytes / Q000473:pathology*; D006801:Humans; D048670:MAP Kinase Kinase 4 / Q000378:metabolism*; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D016686:Monocrotaline / Q000009:adverse effects*; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D000077157:Sorafenib; D017361:Viral Nonstructural Proteins / Q000502:physiology*; D012324:RNA-Dependent RNA Polymerase
chemical_list: D048670:MAP Kinase Kinase 4; D020780:Matrix Metalloproteinase 9; D016686:Monocrotaline; D009536:Niacinamide; D010671:Phenylurea Compounds; D000077157:Sorafenib; D017361:Viral Nonstructural Proteins; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase